Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury

INTRODUCTION: Neutrophil gelatinase-associated lipocalin (NGAL) is a promising novel biomarker that correlates with the severity and outcome of acute kidney injury (AKI). However, its prognostic utility during the late course of AKI, especially in patients that require renal replacement therapy (RRT...

Descripción completa

Detalles Bibliográficos
Autores principales: Kümpers, Philipp, Hafer, Carsten, Lukasz, Alexander, Lichtinghagen, Ralf, Brand, Korbinian, Fliser, Danilo, Faulhaber-Walter, Robert, Kielstein, Jan T
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875521/
https://www.ncbi.nlm.nih.gov/pubmed/20122150
http://dx.doi.org/10.1186/cc8861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875521/
https://www.ncbi.nlm.nih.gov/pubmed/20122150
http://dx.doi.org/10.1186/cc8861

Ejemplares similares